v3.25.2
Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Total
Balance at Dec. 31, 2023         $ 91,469
Balance (in shares) at Dec. 31, 2023         4,939,946
Balance at Mar. 31, 2024         $ 91,469
Balance (in shares) at Mar. 31, 2024         4,939,946
Balance at Dec. 31, 2023 $ 1 $ 1,608 $ (133,649) $ 17 $ (132,023)
Balance (in shares) at Dec. 31, 2023 779,908       786,510
Balance at Mar. 31, 2024 $ 1 1,719 (140,958) 20 $ (139,218)
Balance (in shares) at Mar. 31, 2024 780,069        
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor
Balance at Dec. 31, 2023         $ 91,469
Balance (in shares) at Dec. 31, 2023         4,939,946
Increase (Decrease) in Convertible Preferred Stock          
Exchange preferred stock for pre-funded warrants         $ (4,686)
Exchange preferred stock for pre-funded warrants (shares)         (207,902)
Balance at Jun. 30, 2024         $ 86,783
Balance (in shares) at Jun. 30, 2024         4,732,044
Balance at Dec. 31, 2023 $ 1 1,608 (133,649) 17 $ (132,023)
Balance (in shares) at Dec. 31, 2023 779,908       786,510
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       5 $ 5
Exchange preferred stock for pre-funded warrants   4,332     4,332
Stock option exercises   2     2
Stock option exercises (in shares) 272        
Stock-based compensation   221     221
Net loss     (13,043)   (13,043)
Balance at Jun. 30, 2024 $ 1 6,163 (146,692) 22 $ (140,506)
Balance (in shares) at Jun. 30, 2024 780,180        
Financial Designation, Predecessor and Successor [Fixed List]         Predecessor
Balance at Mar. 31, 2024         $ 91,469
Balance (in shares) at Mar. 31, 2024         4,939,946
Increase (Decrease) in Convertible Preferred Stock          
Exchange preferred stock for pre-funded warrants         $ (4,686)
Exchange preferred stock for pre-funded warrants (shares)         (207,902)
Balance at Jun. 30, 2024         $ 86,783
Balance (in shares) at Jun. 30, 2024         4,732,044
Balance at Mar. 31, 2024 $ 1 1,719 (140,958) 20 $ (139,218)
Balance (in shares) at Mar. 31, 2024 780,069        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment       2 2
Exchange preferred stock for pre-funded warrants   4,332     4,332
Stock option exercises   1     1
Stock option exercises (in shares) 111        
Stock-based compensation   111     111
Net loss     (5,734)   (5,734)
Balance at Jun. 30, 2024 $ 1 6,163 (146,692) 22 $ (140,506)
Balance (in shares) at Jun. 30, 2024 780,180        
Financial Designation, Predecessor and Successor [Fixed List]         Successor
Balance at Dec. 31, 2024 $ 2 90,495 (70,586) 1 $ 19,912
Balance (in shares) at Dec. 31, 2024 15,198,232       15,198,232
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment     62 (100) $ (38)
Shares issued during period (in shares) 183,333        
Stock-based compensation   452     452
Net loss     (11,660)   (11,660)
Balance at Jun. 30, 2025 $ 2 90,947 (82,184) (99) $ 8,666
Balance (in shares) at Jun. 30, 2025 15,381,565       15,381,565
Financial Designation, Predecessor and Successor [Fixed List]         Successor
Balance at Mar. 31, 2025 $ 2 90,713 (78,256) (60) $ 12,399
Balance (in shares) at Mar. 31, 2025 15,381,565        
Increase (Decrease) in Stockholders' Deficit          
Foreign currency translation adjustment     19 (39) (20)
Stock-based compensation   234     234
Net loss     (3,947)   (3,947)
Balance at Jun. 30, 2025 $ 2 $ 90,947 $ (82,184) $ (99) $ 8,666
Balance (in shares) at Jun. 30, 2025 15,381,565       15,381,565